Inactive Trojan Bacteria as Safe Drug Delivery Vehicles Crossing the Blood–Brain Barrier
Brain dead
Efflux
DOI:
10.1021/acs.nanolett.3c00563
Publication Date:
2023-05-02T17:19:17Z
AUTHORS (9)
ABSTRACT
Escherichia coli K1 (EC-K1) can bypass the blood–brain barrier (BBB) and cause meningitis. Excitingly, we find "dead EC-K1" safely penetrate BBB because they retain intact structure chemotaxis of live EC-K1, while losing their pathogenicity. Based on this, develop a safe EC-K1"-based drug delivery system, in which EC-K1 engulf maltodextrin (MD)-modified therapeutics through bacteria-specific MD transporter pathway, followed by inactivation via UV irradiation. We demonstrate that dead bacteria could carry (e.g., indocyanine green (ICG)) together after intravenous injection into mice, delivering ∼3.0-fold higher doses brain than free ICG under same conditions. What is more, all mice remain healthy even 14 days ∼109 CFU inactive bacteria. As proof concept, developed strategy enables therapy bacterial meningitis glioblastoma mice.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (61)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....